Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Health Care Professionals - Alkindi |
Description | ACCURATE DOSING HELPS YOUR PATIENTS KEEP THEIR EYES ON THE Dosing Treatment Challenges Pediatric-specific Strengths Granular Formulation Administration Individual Dosing Stress Dosing Clinical Trials Phase 3 Study |
Keywords | N/A |
WebSite | alkindisprinkle.com |
Host IP | 167.172.157.46 |
Location | United Kingdom |
Site | Rank |
US$5,741,586
Last updated: 2023-05-07 07:44:44
alkindisprinkle.com has Semrush global rank of 1,843,446. alkindisprinkle.com has an estimated worth of US$ 5,741,586, based on its estimated Ads revenue. alkindisprinkle.com receives approximately 662,491 unique visitors each day. Its web server is located in United Kingdom, with IP address 167.172.157.46. According to SiteAdvisor, alkindisprinkle.com is safe to visit. |
Purchase/Sale Value | US$5,741,586 |
Daily Ads Revenue | US$5,300 |
Monthly Ads Revenue | US$158,998 |
Yearly Ads Revenue | US$1,907,974 |
Daily Unique Visitors | 44,167 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
alkindisprinkle.com. | A | 599 | IP: 167.172.157.46 |
alkindisprinkle.com. | NS | 3600 | NS Record: ns07.domaincontrol.com. |
alkindisprinkle.com. | NS | 3600 | NS Record: ns08.domaincontrol.com. |
Dosing Treatment Challenges Pediatric-specific Strengths Granular Formulation Administration Individual Dosing Stress Dosing Clinical Trials Phase 3 Study Extension Study Bioequivalence Study to HC Tablet Bioequivalence Study to HC Tablet & Injection Fasted/Fed Bioequivalence Study Bioavailability Study Support Resources Prescribing Information Medication Guide & IFU For Patients For Healthcare Professionals GET UPDATES > GET UPDATES > ACCURATE DOSING HELPS YOUR PATIENTS KEEP THEIR EYES ON THE FUTURE. ALKINDI SPRINKLE ® (hydrocortisone) oral granules: The first and only FDA-approved hydrocortisone adrenal insufficiency treatment specifically formulated for newborns and children. 1 ALKINDI SPRINKLE is a pediatric-specific hydrocortisone treatment that manages cortisol levels to facilitate more accurate and individualized dosing in infants, children, and adolescents (neonate to <17 years old) with adrenal insufficiency (AI), including congenital adrenal hyperplasia (CAH). 1,2 * |
HTTP/1.1 200 OK Date: Wed, 27 Oct 2021 15:28:39 GMT Server: Apache/2.4.41 (Ubuntu) X-DNS-Prefetch-Control: off Expect-CT: max-age=0 X-Frame-Options: SAMEORIGIN Strict-Transport-Security: max-age=15552000; includeSubDomains X-Download-Options: noopen X-Content-Type-Options: nosniff X-Permitted-Cross-Domain-Policies: none Referrer-Policy: no-referrer X-XSS-Protection: 0 Accept-Ranges: bytes Cache-Control: public, max-age=0 Last-Modified: Mon, 04 Oct 2021 20:20:50 GMT ETag: W/"4906e-17c4cf754d0" Content-Type: text/html; charset=UTF-8 Content-Length: 299118 |
Domain Name: ALKINDISPRINKLE.COM Registry Domain ID: 2507514847_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-03-25T20:35:47Z Creation Date: 2020-03-25T20:35:46Z Registry Expiry Date: 2030-03-25T20:35:46Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T11:53:25Z <<< |